Literature DB >> 30094703

Disposition of ceftobiprole during continuous venous-venous hemodiafiltration (CVVHDF) in a single critically ill patient.

Pier Giorgio Cojutti1,2, Maria Merelli3, Paola De Stefanis4, Cleo Fregonese5, Francesca Lucchese4, Matteo Bassetti2,3, Federico Pea6,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30094703     DOI： 10.1007/s00228-018-2535-0

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  6 in total

1.  Validation of HPLC and UV spectrophotometric methods for the determination of meropenem in pharmaceutical dosage form.

Authors:  Andreas S L Mendez; Martin Steppe; Elfrides E S Schapoval
Journal:  J Pharm Biomed Anal       Date:  2003-12-04       Impact factor: 3.935

2.  Single-dose pharmacokinetics and safety of a novel broad-spectrum cephalosporin (BAL5788) in healthy volunteers.

Authors:  Anne Schmitt-Hoffmann; Brigitte Roos; Michael Schleimer; Jill Sauer; Anthony Man; Norman Nashed; Thomas Brown; Antonio Perez; Erhard Weidekamm; Péter Kovács
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

3.  Accurate detection of outliers and subpopulations with Pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R.

Authors:  Michael N Neely; Michael G van Guilder; Walter M Yamada; Alan Schumitzky; Roger W Jelliffe
Journal:  Ther Drug Monit       Date:  2012-08       Impact factor: 3.681

Review 4.  Scleromyxedema.

Authors:  Laura K Hummers
Journal:  Curr Opin Rheumatol       Date:  2014-11       Impact factor: 5.006

5.  Multiple-dose pharmacokinetics and safety of a novel broad-spectrum cephalosporin (BAL5788) in healthy volunteers.

Authors:  Anne Schmitt-Hoffmann; Lars Nyman; Brigitte Roos; Michael Schleimer; Jill Sauer; Norman Nashed; Thomas Brown; Anthony Man; Erhard Weidekamm
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

Review 6.  Pharmacokinetics and Dosing of Ceftobiprole Medocaril for the Treatment of Hospital- and Community-Acquired Pneumonia in Different Patient Populations.

Authors:  Antonio Torres; Johan Willem Mouton; Federico Pea
Journal:  Clin Pharmacokinet       Date:  2016-12       Impact factor: 6.447
  6 in total
  2 in total

Review 1.  Nosocomial Pneumonia in the Era of Multidrug-Resistance: Updates in Diagnosis and Management.

Authors:  Elena Xu; David Pérez-Torres; Paraskevi C Fragkou; Jean-Ralph Zahar; Despoina Koulenti
Journal:  Microorganisms       Date:  2021-03-05

Review 2.  Antimicrobial Dose Reduction in Continuous Renal Replacement Therapy: Myth or Real Need? A Practical Approach for Guiding Dose Optimization of Novel Antibiotics.

Authors:  Milo Gatti; Federico Pea
Journal:  Clin Pharmacokinet       Date:  2021-06-14       Impact factor: 6.447
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.